FDA Inspection 1238177 — Fresenius Kabi AB
The FDA completed an inspection of Fresenius Kabi AB on Apr 21, 2023 in Uppsala. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Veterinary.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 21, 2023
- Fiscal Year
- 2023
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Uppsala (Sweden)
Additional details
Mutual Recognition Agreement (MRA)